The research is being conducted by Sarah Mansell under the supervision of Dr. Malgorzata Behnke. They say this parasite hasn't been studied in depth in the UK since the 1970's, because the symptoms can be controlled by routine worming measures. However, as the industry moves away from routine worming as a measure of reducing the risk of parasites developing resistances to treatments, a condition such as this which is now considered to be quite rare in the UK can start to re-emerge.
Sarah is asking vets to fill out a short questionnaire to assess awareness of Onchocerca Cervicalis in veterinary practices. The survey includes specific questions about the parasite as well as questions about cases of unresponsive skin conditions because a similarity in symptoms can lead to misdiagnoses that could, in fact, turn out to be Onchocerca Cervicalis.
Sarah said: "Hopefully the findings will raise awareness of this problem and help shape future research in this area."
She added: "I want to get vets thinking about this issue much more than perhaps they are at the moment."
To take part in the survey, visit: https://harper-adams.onlinesurveys.ac.uk/assessing-the-awareness-of-onchocerca-cervicalis-amongst-e-2
It's believed that VetSurgeon.org and VetNurse.co.uk, which run on a platform that predates Facebook, may be the first online communities to require good manners.
Under the new policy, anyone who posts anything in the forums which is sarcastic, belittling, snide, rude or unkind towards another member will face immediate removal from the website.
This marks a very radical change to the previous policy in which members were free to say pretty much what they wanted.
VetSurgeon.org Publisher Arlo Guthrie said: "For years, I felt the right to free speech trumped all, and would rarely intervene.
"When I did, the worst anyone faced was a temporary suspension.
"As time has passed, I've realised the limitations of the written word, especially the short-form, hastily-written word, which can cause real distress.
"We all moderate our language offline, it's just a question of realising that we need a different set of standards online, to account for the lack of facial expression and immediacy of reply, and the public nature of the discussion.
Some people have questioned the new policy, and whether it will stifle proper debate.
Arlo added: "I believe not. It is perfectly possible and OK to disagree with someone, and express that disagreement forcefully, without being sarcastic.
"On the contrary, I think that allowing bad manners has a far more chilling effect on free speech, because it scares off opinions from the majority of more moderate members"
Others have asked whether this new policy is the consequence of the new partnership with Improve International, or proposed new laws surrounding social media.
Arlo said: "Again, no. It was a very personal decision I reached after years of wrestling with the problem. It was precipitated by a series of unkind posts and I just thought 'enough's enough'.
"That said, I am really excited about the prospect of working with Improve to grow the community as somewhere its members can come for high quality clinical content and authoritative opinion, which for sure would be hard to achieve if we don't have a friendly, collaborative atmosphere."
Another issue raised about zero tolerance is whether it is fair that there may be no second chance.
Arlo said: "I've tried loads of things over the years. Warnings. Red cards. Suspensions. None of them work. People just push the boundaries.
"But the moment I said 'zero tolerance', it seems people get the message and moderate themselves accordingly."
"I'm delighted. I want people to think of VetSurgeon.org as somewhere everyone can come for authoritative advice and support, confident of a friendly welcome and the highest standards of online behaviour."
A short film about Ami Sawran MRCVS, who simultaneously works as a vet, an actress and the editor of a lesbian magazine called Reprobait, is being released in Vue West End and Vue Piccadilly cinemas from today.
The film, being shown ahead of big screen blockbusters, is part of a series which make up 1000 Londoners, a project to create a digital portrait of the city.
Each film dips into the life of a Londoner for three minutes. The first ten films being shown over the next two months include one about an entrepreneurial hula-hooper from Hoxton, another featuring the last cloth trader in Shoreditch, one about a cage-fighter on the day of his first professional fight and another about a Big Issue seller who works on the Strand.
Rachel Wang, director of 1000 Londoners, said: “This release gives the people of London an opportunity to see these fascinating documentaries in the greatest way to watch any film in London – on the big screen in the West End. By making this possible Vue Entertainment have been extremely open and forward-thinking in their programming.”
The 1000 Londoners films are currently being released weekly on 1000londoners.com The latest film "Danny" looks below the city into Bazalgette's Victorian sewers, where professional 'flusher' Danny Brackley works. Forthcoming Londoners include an ex-SAS author, a third generation blacksmith from Stepney and a woman who has withdrawn from mainstream society to live on a canal boat.
SPVS/VPMA Congress, which is supported by Boehringer and Citation, will be opened this year by Benjamin Mee, motivational speaker, journalist and the man behind the bestselling book and Hollywood blockbuster "We Bought A Zoo".
Other highlights in the CPD programme include:
The exhibition offers a range of suppliers with advice on marketing, management and business development.
For this year’s President's banquet the theme will be a touch of Moulin Rouge, with high energy festival and party band, RPJ, headed by Rick Parfitt Jnr. Congress will start on Thursday with a Congress Cabaret night, featuring Edinburgh Fringe regulars, Peablossom Academy.
To register and for full details of the programme and sponsors, visit www.spvs-vpma-events.co.uk
The research found that 93% of practices have a washing machine on site, but two thirds of those use a domestic machine rather than a commercial one. 69% of staff also take their uniform home to wash in a domestic machine.
Only commercial machines conform to the WRAS regulations, with thermal disinfection capabilities to minimise the risk of cross infection.
The survey also provided an argument for using a robust commercial machine able to cope with high levels of usage and the variety of materials needing to be cleaned: 83% of practices said they use their machines more than once a day and listed bedding, drapes and gowns as the most common materials that need to be cleaned regularly.
Les Marshall, Sales & Marketing Director at Miele Professional, said: "Our research shows that veterinary staff realise the importance of hygiene when cleaning their laundry. At Miele Professional we understand that preventing infection is key. When caring for animals who need medical care, reliable and effective equipment that can wash items ranging from bedding to gowns to reusable bandages is essential.
"As a leading supplier to the care and hospital sectors, all our machines are tested and approved to Water Regulatory Advisory Scheme (WRAS) category 5 for mains connection in any high-risk establishment."
The company says that in addition to meeting WRAS category 5 requirements, it's machines:
Miele Professional is exhibiting at the London Vet Show and will be holding a seminar on 'Controlling the risk of infection with a commercial laundry system' in the Business Theatre on 18 November, 12-12.50pm.
The seminar will explore the benefits of using a commercial laundry over a domestic machine, best practice around thermal disinfection and why it’s vital for veterinary practices to meet WRAS category 5 requirements.
For more information visit www.miele.co.uk.
Reference
95 respondents were surveyed online in June 2016
The study, titled “The utility of combined urine dipstick analysis and specific gravity measurement to determine feline proteinuria”, assessed the utility of the urine dipstick alone and combined with the urine-specific gravity (USG) for detecting proteinuria in cats.
For the study, the clinical records of cats presenting to a referral hospital between January 2011 and January 2017 were reviewed retrospectively.
To be eligible for inclusion, feline urine samples had to have undergone a complete urinalysis including dipstick evaluation, USG and urine protein-to-creatinine (UPC) measurement.
A total of 121 urine samples were included and diagnostic agreement and test accuracy were calculated for the dipstick test alone and in combination with the USG, using different cut-off values for proteinuria. Receiver-operating characteristic (ROC) curves were also calculated.
Jorge Pérez-Accino, corresponding author for the paper, said: “The diagnostic agreement between the urine dipstick and UPC ratio was poor and did not improve if the USG was considered together with the dipstick.
"A dipstick result of equal or greater than “Trace” (0.1-0.3g/L) had a sensitivity of 81% and a specificity of 31% to detect proteinuria.
"With regards the ROC curves, the area under the curve (AUC) of the urine dipstick alone was poor (0.57). When combined with the USG results, this improved to fair (0.78) but the specificity and negative predictive value (NPV) were still low.”
Nicola Di Girolamo, Editor of JSAP said: “These findings indicate that clinicians should not rely on the results of the urine dipstick test in combination with USG in cats for detecting proteinuria. Instead other quantitative methods, such as UPC ratio, should always be performed to detect proteinuria in cats.”
The full article can be found in the September issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13184
The BSAVA has put together a collection of resources relating to urinalysis and proteinuria, available here: https://www.bsavalibrary.com/content/urinalysis--160
David, who is Head of Clinical Intelligence at Vets Now, came in eighth place with 1,756 votes in this year’s RCVS Council elections.
The place was originally offered to Dr Tom Witte, who came in seventh place. However, due to a change in personal circumstances, he decided not to accept.
Professor Stephen May, RCVS President, said: "The loss of such a young, talented and respected Council member as Sarah has been difficult to come to terms with and she is greatly missed by her fellow Council members and others amongst the profession.
"It is also important to recognise that the New Year will bring us fresh challenges and opportunities and we will face them best with a full complement of Council members. Therefore, I am delighted that David will be joining Council from January and is able to attend his first Council meeting, which will be held in committee, with us on Thursday 18 January.
"The circumstances under which David will be joining us have been extremely sad, but I am sure he will be an excellent addition to our team and I look forward to working with him."
More information about David Leicester, including his candidate biography and manifesto, can be found in the Council election booklet sent out earlier this year and available to download from www.rcvs.org.uk/publications. A video of David talking about what he would bring to RCVS Council can also be found on the College’s YouTube channel: www.youtube.com/rcvsvideos
The plans developed by the Animal and Plant Health Agency (APHA), an agency of the Department for Environment, Food & Rural Affairs (DEFRA), involved the creation of a new role of Certification Support Officers (CSOs), non-veterinarians who would support the work of Official Veterinarians (OVs) in the signing of export health certificates for products of animal origin such as meat, dairy, processed products and animal by-products.
The proposals for the creation of CSOs by APHA has arisen due to concerns about the growth of exports in recent years and the potential for an up to 300% increase in products requiring OV certification if the UK has to certify exports of products of animal origin to the EU once the UK leaves the EU. Under APHA’s plans CSOs will work under the direction of veterinary surgeons and support their certification work (for example, verifying temperature checks), although the final certification will always need to be signed by OVs. The role will not involve certification relating to live animals or germinal products.
At the RCVS Council meeting on Thursday 1 November 2018 Council members agreed to facilitate APHA’s proposals and to make changes to the RCVS requirements so as to allow CSOs to support OVs in their certification work.
Amanda Boag, RCVS President, said: "As we have stated in our recent statement on ‘no-deal’ Brexit, it has been estimated that there would be 325% increase in veterinary certification requirements if the UK leaves the EU without a deal, and with these proposals Defra and APHA are preparing for this by increasing the support available for Official Veterinarians. Furthermore the proposal is in line with the concept of a vet-led team, with veterinary surgeons focusing on tasks only vets can do, whilst delegating some tasks to suitably trained and quality-assured members of our teams.
"We appreciate that there were some concerns over the level of education and training required by CSOs and are glad that the APHA has accommodated those views by increasing the level of education to three A-Levels (or equivalent in Scotland) and clarifying the nature of the training required by CSOs.
"By signalling its support for the proposals, RCVS Council has been assured that the integrity and value of the veterinary signature will be upheld and we are glad that we can play a key role in helping the veterinary profession prepare the UK for leaving the EU."
The RCVS position statement on the potential impact of a ‘no-deal’ Brexit scenario is available at www.rcvs.org.uk/brexit
Vetoquinol has announced the launch of Enisyl-FTM, the first L-Lysine supplement developed for veterinary use in the UK and Ireland.
Vetoquinol says a unique distributing pump and paste formulation will aid compliance in cats that require L-Lysine supplementation and make administration of L-Lysine much easier. Each pump action delivers 1ml of Enisyl-F paste at each press, which can be applied directly into the cat's mouth or on the paw to be licked off. It can also be added to food.
Zorica Agbaba, Enisyl-F's Product manager said: "We are delighted to have launched Enisyl-F and I am sure it will prove very useful to veterinary surgeons, especially when it comes to aiding compliance in cats that require L-Lysine supplementation."
To try Enisyl-F or for more information about the product, contact your local Vetoquinol representative or call Vetoquinol main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number). Alternatively visit http://www.vetoquinol.co.uk/ website.
The paper details the current and potential uses of this rapidly developing technology, and its benefits and risks.
It provides an introduction to AI and its uses in human medicine, small animal, farm and equine practice, radiology and veterinary education.
It also looks at the potential impact on the wellbeing and working life of veterinary teams.
Results from VetCT’s recent survey on the opinions of AI within the veterinary profession are included in the paper.
Julien Labruyère, Chief Innovation Officer at VetCT, said: “This is a crucial moment in the veterinary industry to ensure we have the knowledge and safeguards in place to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"This white paper aims to provide a firm foundation for understanding AI and stimulate discussion on how it may impact both people and animals.”
The paper also calls for the development of industry-wide guidance, standards and regulations to safeguard veterinary teams and animal health and welfare as these tools are deployed.
Julien added: “AI development is accelerating rapidly, with global governments and industries racing to regulate to ensure the benefits outweigh the potential negative impacts of this far-reaching technology.
"It’s vital that opinion leaders, organisations and regulators from across the veterinary world come together and develop guardrails so we can have confidence that AI tools will benefit our teams and our patients.”
https://5345458.hs-sites.com/vetct-ai-white-paper
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
Unite and the British Veterinary Union (BVU) have written to the government asking for the Professional Standards Authority (PSA), which regulates such governing bodies as the General Medical Council, General Dental Council, and Nursing and Midwifery Council (NMC), to have 'scrutiny' of the RCVS.
In a letter to junior minister at the Department for Environment, Food and Rural Affairs, George Eustice, the BVU chair Dr Shams Mir cited the case of Munhuwepasi Chikosi struck off the register of veterinary surgeons by the RCVS in June 2013.
Dr Mir said that this case was "widely seen by the veterinary profession as blatant miscarriage of justice and many expressions of 'outrage' were published in the veterinary press and online.
"One popular online veterinary forum recorded over a thousand posts criticising and challenging various aspects of the decision."
The current statutory duties of the RCVS, established by Royal Charter in 1844, are determined by the Veterinary Surgeons Act (VSA) of 1966, which Unite says is now 'outdated.
Dr Mir said: "BVU petitions the government to extend the remit of the PSA to incorporate the RCVS to ensure appropriate overview and scrutiny.
"The RCVS proposed new Royal Charter could be exploited by the RCVS to give itself proxy powers to introduce incontestable new regulatory measures."
Unite has asked for an urgent meeting with Mr. Eustice.
Unite professional officer Jane Beach said: "Our initiative is designed to safeguard the interests of both the public, and practicing vets and veterinary nurses in the UK.
"Basically, the way that the RCVS is presently constituted means that it is both judge and jury in disciplinary matters. It sets the rules and hands down the judgements - and we believe that an extra layer of scrutiny needs to be introduced which we would like to be the PSA."
Bayer Animal Health has taken over the marketing and sales of the antibiotic Nisamox (tablets containing Amoxicillin and Clavulanic Acid), from Fort Dodge Animal Health.
Under the new arrangement, the design of Nisamox tablet packaging will change to reflect the change of ownership, however, Bayer says the quality of the tablets and the competitive pricing remain unchanged.
Nisamox tablets are licensed for use in cats and dogs to treat infections of the skin, urinary tract, and respiratory tract caused by susceptible Staphylococci, and also to treat enteritis and urinary tract infections caused by susceptible E.coli.
Nisamox tablets will continue to be available in three strengths: 50mg, 250mg, and 500mg. For information on Nisamox tablets, contact your Bayer territory manager.
"We would like to reassure vets, and through them dog owners, that we are constantly reviewing adverse event report data to ensure that the benefits of each UK licenced veterinary medicine product outweighs the risk posed by their potential side-effects.
There are a number of vaccines authorised in the UK containing either two (L2) or four (L4) strains of Leptospira. Based on the most recent periodic safety update report data received for each product, the incidence of adverse animal reactions for all L2 vaccine products combined is 0.015%; for L4 vaccine products this figure is 0.069%.
In other words, the VMD has received fewer than 2 adverse reactions for L2, and fewer than 7 for L4, for every 10,000 doses sold. This includes every suspected adverse event reported, even cases that were considered unclassifiable or were later found to be unrelated to the vaccine.
The overall incidence of suspected adverse reactions for both L2 and L4 vaccine products is therefore considered to be rare."
The aim of the study was to assess the efficacy and adverse effect profile of each individual AED by analysing all available data published and then evaluating how reliable it was.
The researchers gathered, screened and assessed all the information published in peer-reviewed journals and publications. The individual studies were then evaluated based on the quality of evidence, study design, study group sizes, subject enrolment quality and overall risk of bias, as well as the efficacy and safety outcome measures.
Lead-author, Marios Charalambous from Ghent University, said: "We recruited systematic methods to combine, compare and summarise the results of independent studies and, therefore, create more objective and reliable conclusions based on the current evidence. It was a time-consuming, demanding and challenging process, and we hope we provided the clinicians now with essential information which they can use for daily practice."
The researchers found that much of the evidence for the medical treatment of feline epilepsy was based on below-par reporting of efficacy and adverse effect, worse than what was formerly reported in dogs.
The lack of good quality evidence led authors to conclude that it would be: "...rather inaccurate to make definite statements on which one [AED] should be considered as a first or second choice in terms of both efficacy and safety profile. However, if clinicians focus on AED’s efficacy, phenobarbital can be used as first-choice monotherapy and if they focus on AED’s safety, imepitoin or levetiracetam can be used."
Holger Volk, Head of the Department Clinical Science and Services and Professor of Veterinary Neurology and Neurosurgery at the RVC, said: "Not only does this study offer a new perspective on the management of feline epilepsy, but also highlights the importance of the need for trials which provide high quality evidence in order to have more reliable and objective results about the efficacy and safety of the AEDs in feline epilepsy."
The study was published in BMC Veterinary Research (https://doi.org/10.1186/s12917-018-1386-3).
The companies are encouraging the use of CT to direct early, targeted surgical intervention and improve outcomes.
Dr Dean Felkler, Founder and CEO of Exotic Vet Support and senior clinician at Tai Wai Small Animal and Exotic Hospital in Hong Kong, says a recent case of his highlights the importance of accurate and early diagnosis.
A 7yr old rabbit was presented for anorexia and hadn’t passed faeces for over 12hrs.
Dean said: “A full diagnostic investigation was performed.
"From the radiographs it is difficult to appreciate the GDV.
"However, on the CT scan, reported by VetCT, it was very obvious when compared to the normal stomach orientation.”
After initial stabilisation the patient underwent surgery to re-orientate the stomach and an incisional gastropexy was performed.
Following surgery the rabbit recovered well and was eating and passing faeces within 24 hours.
Dr David Reese, Director of VetCT Australia and exotics expert said: “We are able to identify several life-threatening pathologies much more accurately with CT than radiographs.
"This is vital for early correction of acute surgical abdominal conditions to increase the likelihood of a positive outcome.”
VetCT is offering a free trial of its specialist teleradiology and teleconsulting services at: www.vet-ct.com
Photo: VetCT report of a CT scan showing GDV in a rabbit - The pylorus (lime green star) denoted by the thick pyloric wall is located on the left side of the abdomen and the fundus (dark pink star) is right laterally located.
The practice is one of few in the UK to use radioactive iodine (RAI) therapy, which, it says, has an average, a 95% success rate in treating cats with hyperthyroidism.
Stephanie Lalor MRCVS (pictured right), an RCVS Specialist in Feline Medicine at Willows said: "The new therapy is non-invasive and is the gold standard of treatment for cats with hyperthyroidism. It is safe and highly effective and a single injection can be curative. Patients do need to be screened for their suitability and ideally they are treated with medical therapy prior to the RAI.
"Due to the radioactive nature of the treatment, patients must stay with us for 15 days after the injection. Our patients stay in luxury cat condos during their hospitalisation and their day-to-day care is over-seen by our lead radioactive iodine nurse, Vicky Maund."
The new unit is part of a £1 million investment in Willows which includes a dedicated operating theatre for minimally invasive procedures, a range of specialist treatment rooms and more than 40 new kennels.
Toby Gemmill, clinical director at Willows, said: "We are already extremely well placed to offer a wide variety of specialist treatments and this extension has provided us with the space to expand our services further. The new radioactive iodine unit is very exciting and allows us to build on our gold level cat-friendly clinic status."
For more information, visit www.willows.uk.net.
The WellVet Weekend will include a variety of sporting activities, yoga classes, wellbeing workshops and social times, all finished off with a gala dinner. Something for everyone.
Speaking at the gala dinner on the Saturday evening will be Rob Pope. Rob, also known as the 'real-life Forrest Gump' is an emergency vet by night and a marathon runner by day. He's the first person ever to run across the USA four times in one year and he's currently running across the USA for the fifth time. This will be Rob’s first public event following his completion of this epic journey.
Liz Barton, Founder of Vetsnet said: "I love sport and I love this profession, so it's fantastic to be able to organise a weekend dedicated to the physical and mental wellbeing of vets and vet nurses. It promises to be a brilliant weekend, and I’m excited to have Rob Pope join us to share his stories from the road."
Ru Clements, Founding Partner of VetLed said: "We’re excited to create a community which supports veterinary professionals to thrive. The WellVet Weekend is a very special concept with a core mission that we wholeheartedly believe in. We hope we can make a long-lasting positive difference to those who attend the first WellVet Weekend."
For more information and to buy your ticket, visit www.wellvet.co.uk
It is hoped the survey will capture the experiences vets have had reporting ADRs, as well as identifying barriers to the current process which could be used to improve the ease with which ADRs are reported in the future.
PhD student Heather Davies (pictured right), who is leading the research project, said: "The survey is an important opportunity to gain insights into the issues that vets face when dealing with ADRs.
"We want to make the process easier in order to improve the safety of veterinary medicines, and ultimately, we need the help of professionals on the front line in order to do that."
She added: "The survey is relatively short and can be completed anonymously.
"We’re really keen to gather as many of your experiences as possible so we’d like to encourage veterinary professionals to complete it."
The research is being carried out as part of a PhD project funded by the Veterinary Medicines Directorate (VMD) in collaboration with the Small Animal Veterinary Surveillance Network (SAVSNET), based at the university.
The survey is now open and you can take part here: https://liverpool.onlinesurveys.ac.uk/adrs-vet
Any questions about the survey can be addressed directly to the researchers: Heather Davies (PhD student): H.H.Davies@liverpool.ac.uk and/or Dr David Killick (Supervisor): David.Killick@liverpool.ac.uk.
Dr Neil Bryant from the AHT, who is leading the research, said: "EHV is a major welfare concern for horses and foals and causes emotional, as well as financial strains, on horse owners and breeders around the world. It can strike any horse at any time so a vaccine will be of global welfare benefit to all horses, including the thoroughbred and sports horse breeding industries, and would help control this serious and sometimes fatal disease."
As a viral infection, EHV can cause respiratory disease, abortion or fatal illness in new born foals and neurological disease in adult horses, with signs ranging from slight wobbliness through to complete paralysis. The disease can strike any horse at any time because the virus, like other herpesviruses (such as the cold sore virus in humans), becomes dormant within most horses early in their life. It then re-emerges when the animal is later stressed such as when transported or mixed with new horses. A seemingly healthy pregnant mare may suddenly, and without warning, abort her unborn foal or may show signs of respiratory disease including mild fever, coughing and discharge from the nose. A horse which appears fit and well may suddenly show abnormalities when walking and within hours may be unable to stand.
Despite the potential severity and impact of outbreaks, there is still no vaccine that is licensed to protect against the neurological form of the disease and abortions still occur in highly vaccinated horse populations. The AHT says protection afforded by existing vaccines currently in use is sub-optimal, something that was highlighted by the 2016 abortion storm in Hertfordshire in fully vaccinated animals.
Neil added: "We have become aware of a pressing need for progress towards a new and improved EHV-1 vaccine. Just last month, the AHT was again called upon to work with the racing industry and affected parties in dealing with confirmed cases of EHV-1 abortion in premises in Yorkshire and Suffolk."
To that end, the charity has now established the Equine Industries EHV Vaccine Steering Group. Chaired by Professor Joe Brownlie of the RVC, the steering group includes world-renowned experts on both human and equine herpes viruses from a number of research establishments, who have concluded that the most appropriate way forward is for the AHT to design a modified live virus (MLV) vaccine.
After securing funding from a large number of organisations, including the Alborada Trust, EBM Charitable Trust, Horserace Betting Levy Board and the Racing Foundation, Paul Mellon Estate, Thompson Family Charitable Trust, Coolmore Ireland, Newsells Park Stud, Thoroughbred Breeders’ Association and Juddmonte Farms, the AHT has begun its five-year research programme.
Neil added: "We’re at the beginning of a very exciting and potentially ground-breaking vaccine development. Through our research, we will construct different viruses with attenuating mutations and assess their suitability as MLVs. We hope our findings will enable further development by vaccine manufacturers in creating an effective vaccine to protect against the serious clinical signs induced by EHV-1."
The 'Room For Rabbits' campaign follows research in which 38% of vets said they think rabbits’ environment is the most neglected welfare need1, with over a quarter of the UK’s rabbits being kept in inadequate housing conditions, and almost half of them living alone2.
The RAW survey also found that 90% of vets believe that rabbits’ welfare in the UK is improving3.
Room for Rabbits will throw a spotlight on rabbits’ environment, with a variety of initiatives during RAW including vet blogs and videos on how to adapt bunnies’ housing for all seasons, boredom buster ideas, a competition to encourage owners to create a RAW ‘gold standard’ environment, and downloadable packs containing resources for practices to create their own RAW campaigns.
Holly Castle, Senior Brand Manager at Burgess Pet Care, RAAG member and organisers of RAW, said: “We are delighted that RAW continues to have a positive impact, with our survey showing that 90% of vets believe that the welfare of the UK’s rabbits is improving - but there is always more than we can do.
“Since the previous RAW campaign, we have successfully launched RAAG, which recognises that the welfare of these wonderful creatures needs to be high on the agenda year-round.
"By bringing together the expertise of the RAW partners, RAAG is focused on encouraging everyone involved with rabbits to support the first Good Practice Code for rabbits’ welfare in England to ensure it becomes enshrined in law.
"One of the ways to achieve this is through initiatives like RAW, which is the UK’s largest welfare campaign of its kind.
“We recognise that vets’ practices were really stretched last year due to the Covid-19 pandemic, which meant it was difficult to support campaigns like RAW.
"However, following a surge in demand for rabbit ownership in the UK during the past two years, it is vitally important that we educate more owners than ever before and continue to help improve rabbits’ welfare."
“The veterinary community plays a hugely important role in ensuring that owners have access to the right information, and we are urging practices to throw their support behind this year’s RAW to ensure that we reach as many owners as possible.
Professor Ian Ramsey, Past President of the BSAVA, which endorses RAW, said: "The BSAVA is once again delighted to support RAW and the theme of this year’s campaign.
"Rabbits remain one of the most misunderstood pets in the UK, but we are confident that vets across the UK will again show their support for this important campaign to improve the lives of pet rabbits.”
The RAAG is encouraging vets’ practices to sign up to receive updates about RAW at https://www.rabbitawarenessactiongroup.co.uk/raw-pack-reminder/.
Downloadable RAW vet packs will also be available from 6th June.
Virbac has announced that Ovarid is back in stock following the resolution of a manufacturing problem.
The megestrol acetate tablets are indicated for the postponement or prevention of oestrus and the treatment of hypersexuality in male dogs. In cats they are recommended for the prevention or postponement of oestrus and the treatment of miliary dermatitis and eosinophilic granulomata.
Virbac says that because the product is relied on by the owners of many cats suffering from miliary eczema, it has worked to ensure that their welfare is not compromised by recalling unused Ovarid stock from practices to ensure that it could still be provided to those contacting them with emergency cases since the outage began in February.
Senior Product Manager Chris Geddes MRCVS said: "I'd like to express my thanks to practices for bearing with us and particularly to those which returned unused product. This meant that we were able to supply emergency supplies for the treatment of miliary eczema to every practice that asked for it. We also managed to help out some zoos which needed supplies for frisky sea lions and lions."
Ovarid is available in 20mg and 5mg tablets.
The publishers say that many people who prescribe veterinary medicines or who handle them (or bodily fluids that may contain them or their active metabolites) are not aware of the potential harmful effects they can have on human reproduction.
'Handling Veterinary Medicines and Pregnancy' gives up-to-date, evidence-based guidance on which drugs and methods of handling are hazardous; information on the relevant regulations relating to the safe handling of such medicines; and practical guidance on avoiding harm in veterinary practice.
Veterinary Prescriber says that once you have completed the module, you will:
understand the principles of reproductive toxicity
understand how data on the harmful effects of medicines are generated
be aware of the evidence on reproductive harm in veterinary practice
understand what practical measures to take to avoid harm
know where to find helpful information on medicines and pregnancy
For more information, visit: https://www.veterinaryprescriber.org/subscribers/
Bayer Animal Health has announced that it will launch Seresto, a new POM-V collar for cats and dogs that kills fleas and repels and kills ticks for up to eight months, in March.
According to Bayer, Seresto is the first treatment to provide repellency against ticks in both cats and dogs, and represents the fruit of a multidisciplinary effort incorporating the company's research into insecticides, polymers and veterinary parasiticides. The end result is a polymer-based collar that transfers the active ingredients to the lipid layer, from where they are spread by the animal's neutral oils.
Bayer Animal Health group product manager, Caroline Braidwood, said: "Seresto is simple to use on both cats and dogs. And because it is long lasting, it offers pet owners an alternative to those struggling to maintain a monthly routine. Bayer believes in innovation and Seresto is an enhancement to our product portfolio that meets the needs and requirements of pet owners and vets alike in the treatment of ticks and fleas."
Seresto contains two active ingredients - imidacloprid for fast action against fleas and flumethrin, which repels and kills ticks.
Caroline added: "Thanks to Seresto's unique polymer structure the active ingredients are safely locked away in the collar's matrix, and are released directly from the collar surface into the lipid layer of the animal at just the dose needed, ensuring optimal protection is sustained for up to 8 months."
Bayer says that because of its repellent (anti-feeding) effect, Seresto reduces the risk of vector-borne disease transmission - a first for cats. The company also says that because the active ingredients are stored on the inside of the polymer, it doesn't matter if the pet is shampooed and the lipid layer stripped off - the active ingredients are quickly replenished by the collar.
Seresto is odour-free and has a safety release mechanism to prevent strangulation. It is available in three sizes, Seresto Cat for cats less than 8kgs, Seresto Small Dog for dogs up to 8kgs and Seresto Large Dogs, for dogs over 8kg.
For further information about Seresto, contact your Bayer territory manager or call 01635 563000.
Warwick Seymour-Hamilton, a former veterinary surgeon who practised in Kent, has had his third application for restoration to the Register refused by the RCVS Disciplinary Committee this week.
Mr Seymour-Hamilton was struck off in 1994 following an inspection of his premises, equipment and facilities in Orpington, which were found to be in such poor condition that it constituted a risk to the health and welfare of animals brought to the practice and brought the profession into disrepute.
Mr Seymour-Hamilton had made two previous restoration applications in July 1995 and June 2010. Both of these were refused on the grounds of poor preparation for re-entering practice life as, in both cases, he had made no attempt to engage in continuing professional development or visit and observe other veterinary practices.
Representing himself at this week's hearing, Mr Seymour-Hamilton said that, since the 2010 hearing, he had further developed an interest in herbal medicine and, after visiting a number of veterinary practices in continental Europe, had attended the College of Naturopathic Medicine in Dublin, gaining a qualification in herbal and naturopathic medicine. He told the Committee that he currently worked as a herbalist and naturopath with human patients but wanted to widen his work and research to include animal patients.
The Committee was concerned by his answers to a number of questions, Mr Seymour-Hamilton having described the hearing as an 'exploratory meeting' and indicating a lack of knowledge in a number of areas to do with veterinary practice and its regulation. The Committee felt that this demonstrated a fundamental lack of understanding as to its function and terms of reference.
Professor Noreen Burrows, chairing the Committee and speaking on its behalf, said: "The Committee expresses its surprise and concern at the lack of preparation for this hearing by the applicant, given that these issues have arisen at his previous restoration hearings, and that the result of a positive finding in favour of him would be his ability to practise unfettered as a veterinary surgeon forthwith."
In particular the Committee highlighted Mr Seymour-Hamilton's lack of understanding of the regulatory framework for veterinary practice as set out in the RCVS Code of Professional Conduct, the requirements of continuing professional development and what 'fitness to practise' meant, beyond the practical issues of his physical and mental capacity.
Professor Burrows added: "Based on all of the evidence available to the Committee it is very clear that he has failed to satisfy... that he is fit to be restored to the Register and this application is therefore dismissed."
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).